{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T10:20:56Z","timestamp":1777026056620,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.ejphar.2020.172934","type":"journal-article","created":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T11:12:13Z","timestamp":1579173133000},"page":"172934","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["In vitro characterization of the thermoneutral transient receptor potential vanilloid-1 (TRPV1) inhibitor GRTE16523"],"prefix":"10.1016","volume":"871","author":[{"given":"Nils","family":"Damann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregor","family":"Bahrenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannelore","family":"Stockhausen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher J.","family":"Habermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"Lesch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Frank-Foltyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeewoo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jihyae","family":"Ann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Christoph","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2020.172934_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.coph.2016.10.002","article-title":"Transient receptor potential channels in neuropathic pain","volume":"32","author":"Basso","year":"2017","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.172934_bib2","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/sj.bjp.0705652","article-title":"Characterization of the mouse cold-menthol receptor TRPM8 and vanilloid receptor type-1 VR1 using a fluorometric imaging plate reader (FLIPR) assay","volume":"141","author":"Behrendt","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.172934_bib3","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.2174\/156802611796904825","article-title":"TRPV1 activation is not an all-or-none event: TRPV1 partial agonism\/antagonism and its regulatory modulation","volume":"11","author":"Blumberg","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejphar.2020.172934_bib4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejphar.2013.03.003","article-title":"Targeting TRP channels for pain relief","volume":"716","author":"Brederson","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.172934_bib5","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jpain.2017.01.009","article-title":"Safety, pharmacokinetics, and pharmacodynamics study in healthy subjects of oral NEO6860, a modality selective transient receptor potential vanilloid subtype 1 antagonist","volume":"18","author":"Brown","year":"2017","journal-title":"J. Pain"},{"key":"10.1016\/j.ejphar.2020.172934_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/ph9030052","article-title":"TRPV1: a target for rational drug design","volume":"9","author":"Carnevale","year":"2016","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejphar.2020.172934_bib7","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1126\/science.288.5464.306","article-title":"Impaired nociception and pain sensation in mice lacking the capsaicin receptor","volume":"288","author":"Caterina","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2020.172934_bib8","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/39807","article-title":"The capsaicin receptor: a heat-activated ion channel in the pain pathway","volume":"389","author":"Caterina","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2020.172934_bib9","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.172934_bib10","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.pain.2007.06.006","article-title":"The effects of the TRPV1 antagonist SB-705498 on TRPV1 receptor-mediated activity and inflammatory hyperalgesia in humans","volume":"132","author":"Chizh","year":"2007","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2020.172934_bib11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.neulet.2009.12.020","article-title":"Tapentadol, but not morphine, selectively inhibits disease-related thermal hyperalgesia in a mouse model of diabetic neuropathic pain","volume":"470","author":"Christoph","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2020.172934_bib12","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1124\/mol.116.104430","article-title":"Structure-driven pharmacology of transient receptor potential channel vanilloid 1","volume":"90","author":"Diaz-Franulic","year":"2016","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.172934_bib13","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.2174\/156802611796904898","article-title":"Therapeutic targeting of TRP channels--the TR(i)P to pain relief","volume":"11","author":"Eid","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejphar.2020.172934_bib14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/B978-0-12-800181-3.00002-6","article-title":"Temperature sensing by thermal TRP channels: thermodynamic basis and molecular insights","volume":"74","author":"Feng","year":"2014","journal-title":"Curr. Top. Membr."},{"issue":"3","key":"10.1016\/j.ejphar.2020.172934_bib15","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13038","article-title":"TRPV1 antagonists that cause hypothermia, instead of hyperthermia, in rodents: compounds\u2019 pharmacological profiles, in vivo targets, thermoeffectors recruited and implications for drug development","volume":"223","author":"Garami","year":"2018","journal-title":"Acta Physiol."},{"key":"10.1016\/j.ejphar.2020.172934_bib16","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1523\/JNEUROSCI.5150-09.2010","article-title":"Contributions of different modes of TRPV1 activation to TRPV1 antagonist-induced hyperthermia","volume":"30","author":"Garami","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2020.172934_bib17","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.tips.2008.08.003","article-title":"Body-temperature maintenance as the predominant function of the vanilloid receptor TRPV1","volume":"29","author":"Gavva","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2020.172934_bib18","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1124\/jpet.107.125674","article-title":"Repeated administration of vanilloid receptor TRPV1 antagonists attenuates hyperthermia elicited by TRPV1 blockade","volume":"323","author":"Gavva","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2020.172934_bib19","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1523\/JNEUROSCI.4833-06.2007","article-title":"The vanilloid receptor TRPV1 is tonically activated in vivo and involved in body temperature regulation","volume":"27","author":"Gavva","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2020.172934_bib20","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1124\/jpet.104.079855","article-title":"AMG 9810 [(E)-3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)acrylamide], a novel vanilloid receptor 1 (TRPV1) antagonist with antihyperalgesic properties","volume":"313","author":"Gavva","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2020.172934_bib21","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.pain.2008.01.024","article-title":"Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans","volume":"136","author":"Gavva","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2020.172934_bib22","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1523\/JNEUROSCI.3815-04.2005","article-title":"Selective blockade of the capsaicin receptor TRPV1 attenuates bone cancer pain","volume":"25","author":"Ghilardi","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2020.172934_bib23","series-title":"TRP Channels as Therapeutic Targets : from Basic Science to Clinical Use","first-page":"129","article-title":"Clinical and preclinical experience with TRPV1 antagonists as potential analgesic agents","author":"Gomtsyan","year":"2015"},{"key":"10.1016\/j.ejphar.2020.172934_bib24","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4161\/chan.5.3.16291","article-title":"Dissecting TRPV1: lessons to be learned?","volume":"5","author":"Grimm","year":"2011","journal-title":"Channels"},{"key":"10.1016\/j.ejphar.2020.172934_bib25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.pain.2008.11.004","article-title":"Repeated dosing of ABT-102, a potent and selective TRPV1 antagonist, enhances TRPV1-mediated analgesic activity in rodents, but attenuates antagonist-induced hyperthermia","volume":"142","author":"Honore","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2020.172934_bib26","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1124\/jpet.105.083915","article-title":"A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel transient receptor potential type V1 receptor antagonist, relieves pathophysiological pain associated with inflammation and tissue injury in rats","volume":"314","author":"Honore","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2020.172934_bib27","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1046\/j.0953-816x.2001.01591.x","article-title":"VR1 protein expression increases in undamaged DRG neurons after partial nerve injury","volume":"13","author":"Hudson","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejphar.2020.172934_bib28","doi-asserted-by":"crossref","first-page":"8392","DOI":"10.1021\/jm300780p","article-title":"2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as potent transient receptor potential vanilloid 1 (TRPV1) antagonists: structure-activity relationships of 2-amino derivatives in the N-(6-trifluoromethylpyridin-3-ylmethyl) C-region","volume":"55","author":"Kim","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2020.172934_bib29","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1365-2036.2011.04629.x","article-title":"Randomised clinical trial: the efficacy of a transient receptor potential vanilloid 1 antagonist AZD1386 in human oesophageal pain","volume":"33","author":"Krarup","year":"2011","journal-title":"Aliment Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2020.172934_bib30","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1177\/1073858414567884","article-title":"ThermoTRPs and pain","volume":"22","author":"Laing","year":"2016","journal-title":"The Neuroscientist"},{"key":"10.1016\/j.ejphar.2020.172934_bib31","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1124\/jpet.107.132233","article-title":"Antihyperalgesic effects of (R,E)-N-(2-hydroxy-2,3-dihydro-1H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluorom ethyl)phenyl)-acrylamide (AMG8562), a novel transient receptor potential vanilloid type 1 modulator that does not cause hyperthermia in rats","volume":"326","author":"Lehto","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2020.172934_bib32","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12883-017-0836-z","article-title":"Effectiveness of the capsaicin 8% patch in the management of peripheral neuropathic pain in European clinical practice: the ASCEND study","volume":"17","author":"Mankowski","year":"2017","journal-title":"BMC Neurol."},{"key":"10.1016\/j.ejphar.2020.172934_bib33","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1152\/jn.90768.2008","article-title":"Contributions of central and peripheral TRPV1 receptors to mechanically evoked and spontaneous firing of spinal neurons in inflamed rats","volume":"100","author":"McGaraughty","year":"2008","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.ejphar.2020.172934_bib34","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1152\/jn.00560.2005","article-title":"Systemic and site-specific effects of A-425619, a selective TRPV1 receptor antagonist, on wide dynamic range neurons in CFA-treated and uninjured rats","volume":"95","author":"McGaraughty","year":"2006","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.ejphar.2020.172934_bib35","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1113\/jphysiol.2013.251751","article-title":"The role of endogenous molecules in modulating pain through transient receptor potential vanilloid 1 (TRPV1)","volume":"591","author":"Morales-Lazaro","year":"2013","journal-title":"J. Physiol."},{"issue":"12","key":"10.1016\/j.ejphar.2020.172934_bib36","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1111\/bph.14044","article-title":"Targeting nociceptive transient receptor potential channels to treat chronic pain: current state of the field","volume":"175","author":"Moran","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.172934_bib37","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1124\/jpet.111.190314","article-title":"Pharmacology of modality-specific transient receptor potential vanilloid-1 antagonists that do not alter body temperature","volume":"342","author":"Reilly","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2020.172934_bib38","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jpain.2016.09.008","article-title":"Capsaicin 8% patch in painful diabetic peripheral neuropathy: a randomized, double-blind, placebo-controlled study","volume":"18","author":"Simpson","year":"2017","journal-title":"J. Pain"},{"key":"10.1016\/j.ejphar.2020.172934_bib39","doi-asserted-by":"crossref","first-page":"7459","DOI":"10.1523\/JNEUROSCI.1483-07.2007","article-title":"Nonthermal activation of transient receptor potential vanilloid-1 channels in abdominal viscera tonically inhibits autonomic cold-defense effectors","volume":"27","author":"Steiner","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2020.172934_bib40","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1517\/13543784.2012.704021","article-title":"Targeting TRPV1 for pain relief: limits, losers and laurels","volume":"21","author":"Szallasi","year":"2012","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.ejphar.2020.172934_bib41","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0896-6273(00)80564-4","article-title":"The cloned capsaicin receptor integrates multiple pain-producing stimuli","volume":"21","author":"Tominaga","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2020.172934_bib42","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/cne.1063","article-title":"Vanilloid receptor VR1 is both presynaptic and postsynaptic in the superficial laminae of the rat dorsal horn","volume":"436","author":"Valtschanoff","year":"2001","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.ejphar.2020.172934_bib43","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nature02732","article-title":"The principle of temperature-dependent gating in cold- and heat-sensitive TRP channels","volume":"430","author":"Voets","year":"2004","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ejphar.2020.172934_bib44","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","article-title":"Ethical guidelines for investigations of experimental pain in conscious animals.","volume":"16","author":"Zimmermann","year":"1983","journal-title":"Pain"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920300261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920300261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:33:53Z","timestamp":1757975633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299920300261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":44,"alternative-id":["S0014299920300261"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.172934","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro characterization of the thermoneutral transient receptor potential vanilloid-1 (TRPV1) inhibitor GRTE16523","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.172934","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"172934"}}